BNA
Alzheimer’s disease (AD) is a major public health issue. The French National Alzheimer database (BNA) registers all medical acts performed by memory units and independent specialists throughout France.
In 2008, the third French National Plan for ‘Alzheimer and Related Disorders’ 2008–2012 was launched, having the following objectives: to strengthen the research on Alzheimer’s disease (AD) and related disorders, to promote earlier diagnosis and to improve both patient management and support for careers. One specific part of this plan resulted in the creation of the French National Alzheimer Database (BNA) in 2009 aiming to provide epidemiological data as well as activity indicators. The information collected in the BNA consists of a limited set of data (CIMA for Corpus Information Minimum Alzheimer) concerning demographic, diagnostic and clinical details defined by national consensus. The number of variables is restricted to facilitate and enhance the participation in this national database.
Participants are the French memory units [the memory centers (CMs: Consultations Mémoire) and the memory resource and research centers (CMRRs: Centres Mémoire de Ressources et de Recherche)] and independent specialists. In 2015 more than 500 send CIMA to the BNA.
The plan neurodegenerative disease 2014 – 2019 aims to continue and amplify the BNA.
contact : contact@banque-nationale-alzheimer.fr
Scientific articles are available in CoBTek Articles.